Ventyx Biosciences, Inc.·4

Jun 16, 9:16 PM ET

Sandborn William J. 4

4 · Ventyx Biosciences, Inc. · Filed Jun 16, 2023

Insider Transaction Report

Form 4
Period: 2023-06-15
Transactions
  • Sale

    Common Stock

    2023-06-15$33.88/sh2,383$80,73032,279 total(indirect: By Spouse)
  • Sale

    Common Stock

    2023-06-15$34.75/sh1,104$38,36231,175 total(indirect: By Spouse)
Holdings
  • Common Stock

    48,389
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on December 19, 2022.
  • [F2]Represents the weighted average share price of an aggregate total of 2,383 shares sold in the price range of $33.39 to $34.322. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Represents the weighted average share price of an aggregate total of 1,104 shares sold in the price range of $34.445 to $34.9565. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION